Article info
PDFExtended reports
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study
- Correspondence to:
Dr J Kremer
Center for Rheumatology, 1367 Washington Ave Ste 101, Albany, NY 12206 USA; jkremerjoint-docs.com
Citation
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study
Publication history
- Accepted January 16, 2005
- First published January 27, 2005.
Online issue publication
April 09, 2023
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases